Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction

Archives of Neurology

Volumn 53, Issue 11, 1996, Pages 1191-1192

  Privitera, Michael ^a,c   Welty, Timothy E ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; TICLOPIDINE;

ADULT; AMNESIA; ANGINA PECTORIS; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL; SEIZURE;

EID: 0029798278     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550110143027     Document Type: Article

References (11)

1. Desager JP. Clinical pharmacokinetics of ticlopidine. Clin Pharmacokinet. 1994; 5:347-55.
2. Panak E, Maffrand JP, Picard-Praire C, Vallee E, Blanchard J, Roncucci R. Ticlopidine: a promise for the prevention of thrombosis and its complications. Haemostasis. 1983;13(suppl):1-54.
3. Physicians' Desk Reference 1996. Montvale, NJ: Medical Economies; 1996: 2156-2159.
4. Riva R, Cerullo A, Albani F, Baruzzi A. Ticlopidine impairs phenytoin clearance: a case report. Neurology. 1996;46:1172-1173.
5. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995;45:1499-1504.
6. Privitera MD, Homan RW, Ludden TM, Peck CC, Vasko MR. Clinical utility of a bayesian dosing program for phenytoin. Therapeut Drug Monit. 1989;11:285-294.
7. Knudsen JB, Bastain W, Sefton CM, Alien JG, Dickinson JP. Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effect on antipyrine pharmacokinetics. Xenobiotica. 1992;22:579-589.
8. Colli A, Buccino G, Cocciolo M, et al. Ticlopidine-theophylline interaction. Clin Pharmacol Therapeut. 1987;41:358-362.
9. Gidal BE, Sorkness CA, McGill KA, Larson R, Levine RR. Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients. Ther Drug Monit. 1995;17:33-38.
10. Gibaldi M, Perrier D. Apparent volume of distribution. In: Pharmacokinetics. 2nd ed. New York, NY: Marcel Dekker; 1982:199-219.
11. Levy RH. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995;36(suppl):S8-S13.